期刊文献+

圈套寡核苷酸抑制NIH3T3细胞α2Ⅰ型胶原基因表达的研究 被引量:1

An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cells
原文传递
导出
摘要 目的 研究激活剂蛋白 1(activatorprotein 1,AP 1)圈套寡核苷酸 (decoy oligodeoxynu cleotides,Decoy ODNs)对成纤维细胞α2Ⅰ型胶原表达的影响 ,探讨病理性瘢痕的基因治疗。 方法 设计合成针对AP 1的Decoy ODNs,用阳离子脂质体转染NIH3T3细胞 ,观察Decoy ODNs在细胞中的分布 ;用凝胶迁移变动分析 (electrophoreticmobilityshiftassay ,EMSA)研究Decoy ODNs对AP 1的抑制作用 ,采用RT PCR观察其对细胞胶原合成的影响。 结果 AP 1的Decoy ODNs可在体外竞争抑制核转录因子AP 1的活性 ;阳离子脂质体可以将Decoy ODNs转染进入细胞浆及细胞核从而发挥作用 ;Decoy ODNs作用 2 4h后 ,NIH3T3细胞α2Ⅰ型胶原mRNA的表达明显降低。 结论 Decoy ODNs可以通过拮抗核转录因子AP 1的活性而抑制α2Ⅰ型胶的表达。 Objective To investigate the effect of activator protein-1 (AP-1) decoy-oligodeoxynucleotides (Decoy-ODNs) on the expression of fibroblast α2 type I collagen, so as to explore the gene therapy of pathologic scar. Methods Decoy-ODNs targeting AP-1 were designed and synthesized. NIH3T3 cells were transfected by cationic liposomes. The distribution of Decoy-ODNs in the cells was investigated. The inhibiting effects of Decoy-ODNs on AP-1 were determined by electrophoretic mobility shift assay (EMSA). And the effects of Decoy-ODNs on the collagen synthesis in the cells were analyzed by RT-PCR. Results AP-1 Decoy-ODNs could competitively inhibit the AP-1 in vitro activity . Cationic liposomes could play roles by effectively transfecting Decoy-ODNs into the plasma and nucleus. The mRNA expression of fibroblast α2 type I collagen decreased evidently after 24 hours of Decoy-ODNs action. Coclution Decoy-ODNs could inhibit the mRNA expression of fibroblast α2 type I collagen by antagonizing AP-1.
出处 《中华烧伤杂志》 CAS CSCD 2003年第3期175-178,共4页 Chinese Journal of Burns
基金 国家自然科学基金资助项目 (C0 3 0 2 0 4) 国家重点基础研究发展规划资助项目 (G19990 5 42 0 3 ) 重庆市卫生局课题
关键词 圈套寡核苷酸 NIH3T3细胞 α2I型胶原 基因表达 成纤维细胞 Decoy-oligodeoxynucleotides Activator proteinp-1 α2 type I collagen Fibroblast
  • 相关文献

参考文献8

  • 1Kouba DJ, Chung KY, Nishiyama T, et al. Nuclear Factor-κB medi-ates TNF- alnhibition Effect ON α2 (Ⅰ) Collagen ( COL1 A2 ) Gene Transcription in Human Dermal Fibroblasts. J Immunology, 1999,162:4226 - 4234.
  • 2Mann M J, Whittemore AD, Donaldion MC,et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the prevent single-center, randomised, controlled trail. In vivo transfection of cis el-ement“decoy” against NFkB binding site prevented myocardial infarction as gene therapy. The Lancet, 1999,354:1493 - 1498.
  • 3Nirol CS, Devalaraja R, Nanney LB, et al. Chemokine and chemokine recetor expression in keloid and normal fibroblasts. Wound RepReg.2000.8:371 -382.
  • 4Maatta A, Glumoff V, Paakkonen P, et al. Nuclear factor binding to an AP - 1 site is associated with the activation of pro-alpha 1 (Ⅰ) -col-lagen gene in dedifferentiating chondrocytes. Biochem J, 1993,294:365 - 371.
  • 5Chung KY, Agarwal A, Uitto J,et al. An AP-1 binding sequence is essential for regulation of the human alpha2 (Ⅰ ) collagen ( COL1 A2 )promoter activity by transforming growth factor-beta. J Biol Chem,1996. 271:3272-3278.
  • 6Morishita R, Higaki J,Tomita N, et al. Application of transcription factor“decoy” strategy as means of gene therapy and study of geng expression in cardiovascular disease. Cite Res, 1998,82 : 1023 - 1028.
  • 7Varga J, Jimenez SA. Modulation of collagen gene expression and its relation to fibrosis in systemic sclerosis and other fibrotic diorders.Ann Inter Med, 1995,12:60 - 63.
  • 8Adzick NS, Lorenz HP. Cells, matrix, growth factor and the surgen :the biology of scarless fetal wound repair. Ann Surg, 1994, 220:10 -18.

同被引文献14

  • 1鲁峰,高建华.携带Fas基因重组腺病毒治疗瘢痕疙瘩的体外研究[J].中国修复重建外科杂志,2005,19(1):35-38. 被引量:14
  • 2宋保强,鲁开化,郭树忠,李荟元,张阳,胡佩臻,夏炜.重组血管生成抑制剂Ad-METH-1对兔耳增生性瘢痕的抑制[J].中国实用美容整形外科杂志,2005,16(6):377-380. 被引量:10
  • 3付小兵,程飚.病理性瘢痕治疗现状与展望[J].中华整形外科杂志,2006,22(2):146-149. 被引量:31
  • 4[3]REID R R,TOY N MOGFORD F E,et al.Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-βreceptor Ⅱ[J].J Plas Reconstru Aesthet Surg,2007,60(1):64-72.
  • 5[4]MORISHITA R,HIGAKI J,TOMITA N,et a1.Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease[J].Circ Res,1998,82(10):1023-1028.
  • 6[6]KIM C W,SUH S L,SUNG S H,et al.A transcriptional factor decoy against AP-1 suppresses TGF-bate1-induced type I collagen gene expression in cultured keloid fibroblasts[J].J Dermatol Sci,2005,37(1),49-51.
  • 7[8]RAMCHANDRAN R,DHANABAL M,VOLK R,et al.Antiangiogenic activity of restin,NC10 domain of human collagen XV:comparison to endostation[J].Biochem Biophys Res Commun,1999,255(3):735-739.
  • 8[10]CHODON T,SUGIHARA T,IGAWA H H,et al.Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-bate1 can abrogate this resistance[J].Am J Pathol,2000,157(5):1661-1669.
  • 9[11]CROWSTON J G,CHANG L H,CONSTABLE P H,et al.Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblast[J].Invest Ophthalmol Vis Sci,2002,43(3):692-699.
  • 10[13]NAKAZONO-KUSABA A,TAKAHASHI-YANAGA F,MIWA Y,et al.PKC412 induces apoptosis through a caspase-dependent mechanism in human keloid-derived fibroblasts[J].Eur J Pharmacol,2004,497(2):155-160.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部